NEW YORK (GenomeWeb) – Belgian diagnostics company MDxHealth reported before the opening of the market on Thursday that its full-year 2016 revenues rose 70 percent, driven by strong growth in its ConfirmMDx prostate cancer test and the launch of its SelectMDx liquid biopsy test.

The company reported total revenues of $30.0 million, up from $17.6 million in 2015. Of the total, US revenues rose 60 percent to $24.4 million from $15.2 million in 2015, and non-US revenues rose 133 percent to $5.6 million from $2.4 million.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Berkeley researchers have engineered yeast to make the molecule behind the hoppy taste of beer, Quartz reports.

King's College London researchers examine the influence of school type and genetics on academic achievement.

FiveThirtyEight writes that most who take a direct-to-consumer BRCA1/2 genetic test won't learn much from it.

In Science this week: early life experience influence somatic variation in the genome, and more.